Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|June 26, 2024
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Diego Villa Clé, Jin Seok Kim, et al.
Mycoses|April 3, 2020
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Markus Ruhnke, Oliver A Cornely, Martin Schmidt-Hieber, et al.
Hemasphere|April 25, 2023
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified CriteriaMareike Tometten, Martin Kirschner, Robert Meyer, et al.
Trials|September 16, 2021
Comprehensive support for families with parental cancer (Family-SCOUT), evaluation of a complex intervention: study protocol for a non-randomized controlled trialMarc Dohmen, Andrea Petermann-Meyer, Daniel Blei, et al.
Annals of Hematology|December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
Blood Advances|February 12, 2025
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohortMareike Tometten, Fabian Beier, Martin Kirschner, et al.
Leukemia|March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesJohannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Nature Medicine|December 7, 2021
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trialJason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Annals of Hematology|July 21, 2017
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phaseMohamad Jawhar, Nicole Naumann, Juliana Schwaab, et al.
Oncotarget|December 5, 2014
PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignanciesMatthias Scheffler, Marc Bos, Masyar Gardizi, et al.
Pageof 13